Volume 17, Number 12—December 2011
Letter
Porcine and Human Community Reservoirs of Enterococcus faecalis, Denmark
Table A1
ID (other name) | Origin† | Setting | Sampling year | MLST† | PFGE‡ | Biofilm formation | Virulence-associated genes | PAI genes | Resistance profile |
---|---|---|---|---|---|---|---|---|---|
31438-1 | IE patient | HA | 1997 | 97 | A | Weak | ebpA gelE hylA ef1896 ef2505 ace | cbh | None |
130529 | IE patient | HA | 2000 | 97 | A | Weak | ebpA gelE hylA ef1896 ef2505 ace | cbh | None |
67190 | IE patient | CA | 2002 | 97 | A | Weak | ebpA gelE hylA ef1896 ef2505 ace | cbh | None |
7330616-3 (D30) | Pig | NA | 2001 | 97 | A | Weak | ebpA gelE hylA ef1896 ef2505 ace | cbh | None |
28137 | IE patient | HA | 1996 | 72 | B | None | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
7684 | IE patient | HA | 1997 | 72 | B | Weak | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
33873 | IE patient | HA | 2002 | 72 | B | Medium | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
1293 | CD human | NA | 2003 | 72 | B | Medium | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
3527 | CD human | NA | 2006 | 72 | B | Medium | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
1745 | CD human | NA | 2004 | 72 | U1 | Weak | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | TET |
43674 | IE patient | CA | 1999 | 19 | C | Medium | ebpA gelE ef2505 hlyB ace | None | ERY TET |
2247 | CD human | NA | 2004 | 19 | C | Medium | ebpA gelE ef2505 hlyB ace | cbh esp | CIP ERY TET |
54869 | IE patient | HA | 1997 | 40 | D | Weak | ebpA gelE hylA ef2505 hlyB ace | cbh | KAN STR TET |
7330082-2 (D1) | Pig | NA | 2001 | 40 | D | Medium | ebpA gelE hylA ef2505 hlyB ace | cbh esp | None |
7330321-1 (D27) | Pig | NA | 2001 | 40 | D | Medium | ebpA gelE hylA ef2505 hlyB ace | cbh esp | CHL ERY KAN STR TET |
7331063-5 (D37) | Pig | NA | 2001 | 40 | D | None | ebpA gelE hylA ef2505 hlyB ace | cbh | STR |
7330887-1 (D32) | Pig | NA | 2001 | 40 | U2 | None | ebpA gelE hylA ef2505 hlyB ace | cbh | ERY STR |
26669 | IE patient | HA | 1998 | 21 | E | Weak | ebpA gelE hylA ef2505 hlyB ace | cbh | None |
3162 | CD human | NA | 2005 | 21 | E | Weak | ebpA gelE hylA ef2505 ace | cbh esp | TET |
105049 | IE patient | CA | 1997 | 306 | E | Medium | ebpA gelE hylA ef1896 ef2505 ace | cbh esp | None |
127801 | IE patient | CA | 1999 | 306 | F | Medium | ebpA gelE hylA ef1896 ef2505 ace | cbh esp | None |
2421 | CD human | NA | 2004 | 306 | F | Medium | ebpA gelE hylA ef1896 ef2505 ace | cbh esp | None |
57690 | IE patient | HA | 2000 | 22 | NA | Weak | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
20505-1 | IE patient | HA | 2000 | 30 | NA | Weak | ebpA gelE hylA ef1896 ef2505 ace | esp | TET |
100087 | IE patient | HA | 1999 | 41 | NA | Weak | ebpA gelE hylA ef1896 ef2505 ace | cbh esp | ERY KAN STR TET |
105158 | IE patient | HA | 1997 | 55 | NA | Medium | ebpA hylA ef1896 ef2505 hlyB ace | cbh esp | CHL ERY KAN STR TET |
134125 | IE patient | HA | 2000 | 55 | NA | Strong | ebpA hylA ef1896 ef2505 hlyB ace | cbh esp | CHL ERY KAN STR TET |
29783 | IE patient | HA | 1999 | 81 | NA | Medium | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh ef0571 | None |
120903 | IE patient | CA | 1999 | 192 | NA | Medium | ebpA gelE ef1824 hylA ef2505 hlyB ace | None | TET |
107137 | IE patient | HA | 2001 | 241 | NA | Weak | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh ef0571 | None |
83232 | IE patient | CA | 1997 | 326 | NA | Strong | ebpA gelE hylA ef1896 ef2505 ace | cbh esp | None |
1149 | CD human | NA | 2003 | 133 | NA | Strong | ebpA hylA ef1896 ef2505 ace | cbh | TET |
3392 | CD human | NA | 2005 | 133 | NA | Medium | ebpA hylA ef1896 ef2505 ace | cbh | None |
1732 | CD human | NA | 2003 | 141 | NA | None | ebpA gelE ef1824 hylA ef2505 hlyB ace | None | CIP |
1028 | CD human | NA | 2003 | 168 | NA | Strong | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
1309 | CD human | NA | 2003 | 168 | NA | Strong | ebpA gelE ef1824 hylA ef2505 hlyB ace | cbh | None |
1413 | CD human | NA | 2003 | 199 | NA | Medium | ebpA gelE ef1824 hylA ef2505 ace | cbh | None |
2174 | CD human | NA | 2004 | 206 | NA | Weak | ebpA hylA ef2505 ace | cbh | TET |
2041 | CD human | NA | 2004 | 327 | NA | Weak | ebpA hylA ef2505 ace | cbh | TET |
*MLST, multi-locus sequence typing; PFGE, pulsed-field gel electrophoresis; PAI, pathogenicity island; IE, infective endocarditis; CD, community-dwelling; HA, healthcare-associated infection; CA, community-acquired infection; NA, not applicable; CHL, chloramphenicol; CIP, ciprofloxacin; ERY, erythromycin, KAN, kanamycin; STR, streptomycin; TET, tetracycline.
†STs from 5 pig isolates (in italics) have been published previously (7); the remaining 14 pig isolates belonging to other STs (ST1, ST6, ST16, ST26, ST47, ST63, ST96, ST98, ST99, and ST100) were not included in further analysis.
‡Isolates with similar PFGE banding patterns (>82% relatedness) received the same letter designation (A–F) to reflect their genetic relatedness; highly divergent PFGE banding patterns were designated as unique (U) types (U1 and U2).
References
- Arias CA, Murray BE. Enterococcus species, Streptococcus bovis group and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. p. 2643–53.
- Ruiz-Garbajosa P, Canton R, Pintado V, Coque TM, Willems R, Baquero F, Genetic and phenotypic differences among Enterococcus faecalis clones from intestinal colonisation and invasive disease. Clin Microbiol Infect. 2006;12:1193–8. DOIPubMedGoogle Scholar
- Larsen J, Schønheyder HC, Lester CH, Olsen SS, Porsbo LJ, Garcia-Migura L, Porcine-origin gentamicin-resistant Enterococcus faecalis in humans, Denmark. Emerg Infect Dis. 2010;16:682–4.PubMedGoogle Scholar
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8. DOIPubMedGoogle Scholar
- Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis. 2001;33:990–6. DOIPubMedGoogle Scholar
- Ruiz-Garbajosa P, Bonten MJ, Robinson DA, Top J, Nallapareddy SR, Torres C, Multilocus sequence typing scheme for Enterococcus faecalis reveals hospital-adapted genetic complexes in a background of high rates of recombination. J Clin Microbiol. 2006;44:2220–8. DOIPubMedGoogle Scholar
- Shankar N, Baghdayan AS, Willems R, Hammerum AM, Jensen LB. Presence of pathogenicity island genes in Enterococcus faecalis isolates from pigs in Denmark. J Clin Microbiol. 2006;44:4200–3. DOIPubMedGoogle Scholar
- Mohamed JA, Huang W, Nallapareddy SR, Teng F, Murray BE. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun. 2004;72:3658–63. DOIPubMedGoogle Scholar
- Tsigrelis C, Singh KV, Coutinho TD, Murray BE, Baddour LM. Vancomycin-resistant Enterococcus faecalis endocarditis: linezolid failure and strain characterization of virulence factors. J Clin Microbiol. 2007;45:631–5. Epub 2006 Dec 20. DOIPubMedGoogle Scholar
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement M100-S21. Wayne (PA): The Institute; 2011.